Exagen (XGN) Net Equity Issued and Repurchased (2021 - 2025)

Exagen's (XGN) quarterly Net Equity Issued and Repurchased came in at -$38000.0 in Q4 2025, down 101.12% on a QoQ basis from $3.4 million in Q3 2025.

Exagen (XGN) Net Equity Issued and Repurchased (2021 - 2025) Analysis & Trends

Exagen (XGN) has 2 years of Net Equity Issued and Repurchased data on file, last reported at -$38000.0 in Q4 2025.

Quarterly Net Equity Issued and Repurchased changed N/A year-over-year to -$38000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $3.4 million (changed N/A YoY) and the FY2025 annual result came in at $3.4 million, changed N/A from the prior year.
Net Equity Issued and Repurchased declined to -$38000.0 in Q4 2025, from $3.4 million in the prior quarter.
In the past five years, Net Equity Issued and Repurchased ranged from a high of $69.1 million in Q1 2021 to a low of -$38000.0 in Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Net Equity Issued (Qtr)
1	Thermo Fisher Scientific	234.15 Bn	230.09 Bn	8.34 Bn	-
2	Danaher	152.10 Bn	147.75 Bn	3.61 Bn	-
3	Natera	48.48 Bn	47.38 Bn	486.15 Mn	-
4	Agilent Technologies	44.35 Bn	42.55 Bn	990.00 Mn	-
5	Iqvia Holdings	43.68 Bn	41.60 Bn	1.44 Bn	-
6	Idexx Laboratories	43.02 Bn	42.83 Bn	779.09 Mn	-
7	Illumina	34.39 Bn	33.22 Bn	770.00 Mn	-
8	Mettler Toledo International	28.29 Bn	28.24 Bn	650.22 Mn	-
9	Labcorp Holdings	27.51 Bn	27.37 Bn	1.11 Bn	-
10	Exagen	181.48 Mn	156.88 Mn	12.22 Mn	-

Download Data